Intuitive Surgical, Inc. (NASDAQ:ISRG) released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.79 by $0.16, Bloomberg Earnings reports. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business had revenue of $756.20 million for the quarter, compared to analyst estimates of $724.51 million. During the same quarter in the prior year, the company posted $5.62 earnings per share. Intuitive Surgical’s revenue was up 12.8% on a year-over-year basis.
Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 1.00% during mid-day trading on Friday, hitting $941.20. The stock had a trading volume of 487,001 shares. The firm has a market capitalization of $34.97 billion, a price-to-earnings ratio of 45.08 and a beta of 0.39. The stock’s 50-day moving average is $937.40 and its 200 day moving average is $815.32. Intuitive Surgical has a 1-year low of $610.71 and a 1-year high of $974.66.
In other Intuitive Surgical news, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $917.27, for a total value of $917,270.00. Following the sale, the director now owns 3,787 shares in the company, valued at $3,473,701.49. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Curet Myriam sold 3,385 shares of the company’s stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $837.21, for a total transaction of $2,833,955.85. Following the completion of the sale, the senior vice president now owns 2,657 shares in the company, valued at approximately $2,224,466.97. The disclosure for this sale can be found here. Insiders have sold 37,498 shares of company stock worth $34,533,846 in the last quarter. 2.50% of the stock is owned by corporate insiders.
A number of large investors have recently made changes to their positions in ISRG. Bessemer Group Inc. boosted its stake in Intuitive Surgical by 230.4% in the second quarter. Bessemer Group Inc. now owns 760 shares of the medical equipment provider’s stock worth $711,000 after buying an additional 530 shares during the last quarter. CIBC Asset Management Inc boosted its stake in Intuitive Surgical by 1.9% in the second quarter. CIBC Asset Management Inc now owns 5,468 shares of the medical equipment provider’s stock worth $5,115,000 after buying an additional 101 shares during the last quarter. Alpha Cubed Investments LLC boosted its stake in Intuitive Surgical by 16.6% in the second quarter. Alpha Cubed Investments LLC now owns 547 shares of the medical equipment provider’s stock worth $512,000 after buying an additional 78 shares during the last quarter. IBM Retirement Fund boosted its stake in Intuitive Surgical by 113.1% in the second quarter. IBM Retirement Fund now owns 897 shares of the medical equipment provider’s stock worth $938,000 after buying an additional 476 shares during the last quarter. Finally, Shell Asset Management Co. boosted its stake in Intuitive Surgical by 25.9% in the second quarter. Shell Asset Management Co. now owns 8,996 shares of the medical equipment provider’s stock worth $8,415,000 after buying an additional 1,851 shares during the last quarter. Institutional investors and hedge funds own 97.56% of the company’s stock.
ISRG has been the topic of a number of recent analyst reports. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research report on Monday, April 24th. Barclays PLC reissued a “buy” rating and set a $830.00 price target (up previously from $800.00) on shares of Intuitive Surgical in a research report on Wednesday, April 19th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $1,100.00 target price (up previously from $850.00) on shares of Intuitive Surgical in a research report on Saturday, July 22nd. Leerink Swann reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, July 5th. Finally, Royal Bank Of Canada increased their price target on Intuitive Surgical from $800.00 to $950.00 and gave the stock a “sector perform” rating in a research report on Tuesday, July 18th. Six analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Intuitive Surgical currently has an average rating of “Buy” and a consensus price target of $980.03.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/07/30/intuitive-surgical-inc-isrg-releases-earnings-results-beats-estimates-by-0-16-eps-updated.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
